Quick Answer
CollPlant Biotechnologies Ltd reported Operating Income of -$11.48 million for fiscal year 2025.
CollPlant Biotechnologies Ltd Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$11.48M | +33.4% |
| 2024 | -$17.25M | -129.6% |
| 2023 | -$7.51M | +56.1% |
| 2022 | -$17.10M | -26403.1% |
| 2021 | $65.0K | +101.2% |
| 2020 | -$5.60M | +26.6% |
| 2019 | -$7.63M | -79.8% |
| 2018 | -$4.25M | — |
- CollPlant Biotechnologies Ltd showed an increase of +33.4% in Operating Income compared to the prior fiscal year.
- Over the 2018–2025 period, CollPlant Biotechnologies Ltd’s operating income has declined by 170.5% (from -$4.25 million to -$11.48 million).
- The most recent figure is from CollPlant Biotechnologies Ltd’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: